In vitro and in vivo photosensitizing applications of Photofrin® in malignant melanoma cells

Cheng Jen Chang, Jau Song Yu, Fu Chan Wei

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)


Background: The object of the present study was to evaluate the feasibility of photodynamic therapy (PDT) for malignant melanomas through in vivo and in vitro processes. Methods: Photofrin® (porfimer sodium) was evaluated through in vitro processes with human malignant melanoma cells (MMCs). The in vitro absorption and photosensitizing activity of Photofrin® was examined in an MMC culture system. The in vivo biological activity of Photofrin® applied to subcutaneous implanted melanoma (SIM) in nude mice and exposed to different total light dosages at 630 nm was studied by determining the destruction of the tumors. Subcelluar localization and binding were observed under a fluorescent confocal microscope. Results: MMCs incubated with Photofrin® at a concentration of about 3.5 μg/ml and exposed to laser light at 630 nm with a power density of 100 mW/cm2, showed 50% cell killing. An electron microscopic study demonstrated significant destruction of the target after PDT. Conclusion: Detection of the photosensitizer Photofrin® was localized and its distribution fully observed. PDT-Photofrin® has the capability to destroy MMCs through in vitro and in vivo SIM treatment.

Original languageEnglish
Pages (from-to)260-267
Number of pages8
JournalChang Gung Medical Journal
Issue number3
Publication statusPublished - May 2008
Externally publishedYes


  • Malignant melanoma
  • Photodynamic therapy (PDT)
  • Photosensitizer

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'In vitro and in vivo photosensitizing applications of Photofrin® in malignant melanoma cells'. Together they form a unique fingerprint.

Cite this